Efficacy and safety study of nivolumab in NSCLC patients with untreated or progressing CNS metastases.
Phase of Trial: Phase II
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2016 New trial record